J9301 Obinutuzumab injection
J-Codes
Also known as: obinutuzumab, Gazyva
Injection of obinutuzumab, an anti-CD20 monoclonal antibody. Type II B-cell depleting antibody for lymphoma and chronic lymphocytic leukemia.
Clinical Context
Used for chronic lymphocytic leukemia with fludarabine and cyclophosphamide, and for follicular lymphoma with bendamustine.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.